Ocio EM, Efebera YA, Hájek R, Straub J, Maisnar V, Eveillard J-R, Karlin L, Mateos M-V, Oriol A, Ribrag V, Richardson PG, Norin S, Obermüller J, Bakker NA, Pour L. ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study. Haematologica 2024;109(3):867-876; https://doi.org/10.3324/haematol.2023.283490.